about
Erythrocyte G protein as a novel target for malarial chemotherapySynergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor RapamycinEffectiveness of Multiple Blood-Cleansing Interventions in Sepsis, Characterized in Rats.Quantitative modeling of dose–response and drug combination based on pathway networkLnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transductionMechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemiaPeripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptiveNilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomasSynergistic analgesia of duloxetine and celecoxib in the mouse formalin test: a combination analysisCurcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stabilityIn-depth analysis shows synergy between erlotinib and miR-34aReactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General CaseAdolescent Maturation of Dopamine D1 and D2 Receptor Function and Interactions in RodentsCannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury painThe Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexedAn Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitorsOxycodone combinations for pain relief.Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signalingAn enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data.Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistanceCysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesotheliomaClass I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancerBeta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk.Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage.Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.Does anesthetic additivity imply a similar molecular mechanism of anesthetic action at N-methyl-D-aspartate receptors?Effect of the Combination of CI-988 and Morphine on Neuropathic Pain after Spinal Cord Injury in Rats.Inhibiting spinal neuron-astrocytic activation correlates with synergistic analgesia of dexmedetomidine and ropivacaine.Lactaptin induces p53-independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts.
P2860
Q21144682-676B355F-F644-4D80-B7F1-7A503D663D48Q24811525-1C179D32-7BA5-499B-92B4-6548859BE986Q27320514-3F8BEC73-921F-4513-8E29-26C5866413A2Q27902294-07330E57-32CA-4E6A-B651-C27C36994D72Q28287126-DF706460-8A53-4373-9AD9-E0193320BF5CQ28385690-47387E53-0D70-499F-B57A-6CCA270D65ACQ28396233-33A7D54B-ADEA-4585-9DB7-F0FBB422ED36Q28483929-2327A615-D7FA-4986-96B9-B3A5C5E99286Q28534142-5EC5007D-CE7E-4A3A-B157-87867471A17CQ28538024-DA7B1CDB-8779-4A86-8825-B251516772C0Q28539851-2A39CF1D-0643-4C6C-AC67-FB9497C513AEQ28540022-6855C841-D80F-4423-88BC-07DAF321DEDEQ28550867-C1468761-A21B-4EB5-A291-99E3CDC1364FQ28552647-1E3384F1-6DBD-4769-99A6-6D811BEE924AQ28575056-925A4B4B-62B0-402F-B116-034D5A4CB739Q30733453-5C97C0D5-5471-4C54-8586-880C37A315FBQ33274781-E4046A3F-BCAA-4865-A7FD-D5D88327DD5AQ33580906-D01AD804-38A4-46BD-8B10-223493FC130AQ33702325-435AC13A-E1FE-486C-ACC1-4F0751EEB590Q33713626-F04E7C4A-DFF6-49D2-B89C-EBFECACDBF75Q33757127-7464062A-52F5-406F-B971-76E1A3DD4941Q33886682-0416CB90-FA7A-4A74-BDD9-2C84C7CE217EQ33936078-11DA687E-E4C5-4B31-BFBB-2726642F3387Q33965570-883AE923-E6B6-4618-A7CD-5D9411D63049Q33999619-4CFAB4A3-DFCA-4955-86FC-039C97C7B393Q34045221-5163E666-8C2D-4493-BCB9-2ABD67AAF6D0Q34125281-9205BA34-FEB9-489B-886B-BB70ADFB7ADBQ34271064-3550CDC0-DD78-4C15-A46A-0C24F8AD410BQ34318452-EA9D2F71-20A5-405F-AA07-76D8E0144891Q34350245-4903C432-F86A-44B1-ABF5-3FA799DF58FBQ34365708-4A77D3D7-0D52-4EF3-851D-47081D0B5AA8Q34558945-A8DED99C-AAFB-43BB-A343-D04AB6784934Q34662207-72CB331F-96FD-484F-995D-F7ED842DE0B8Q34971908-657D3C7B-8D3F-4519-85B2-0BE427A36A1FQ35007971-AF65CECA-27AF-4979-8471-29FC192BFC46Q35048705-13F1FBE9-E505-447A-B319-5A997CDCF7AEQ35109846-1FF74C51-59D8-4844-8500-6CF6DF58D5CEQ35127461-5F9881FF-5C53-40F7-A505-70D2E4343473Q35128106-2C91667C-0721-4550-BBEC-811071C6943DQ35141879-63F38423-3E1A-4462-AA8A-168F9D926D57
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug synergism: its detection and applications.
@ast
Drug synergism: its detection and applications.
@en
Drug synergism: its detection and applications.
@nl
type
label
Drug synergism: its detection and applications.
@ast
Drug synergism: its detection and applications.
@en
Drug synergism: its detection and applications.
@nl
prefLabel
Drug synergism: its detection and applications.
@ast
Drug synergism: its detection and applications.
@en
Drug synergism: its detection and applications.
@nl
P1476
Drug synergism: its detection and applications.
@en
P2093
Tallarida RJ
P304
P407
P577
2001-09-01T00:00:00Z